Internet-delivered Cognitive Behavior Therapy for Adolescents With Functional Gastrointestinal Disorders: a Pilot Study
Launched by KAROLINSKA INSTITUTET · Jan 9, 2014
Trial Information
Current as of May 06, 2025
Completed
Keywords
ClinConnect Summary
Functional gastrointestinal disorders (FGID), including irritable bowel syndrome (IBS), functional dyspepsia (FD) and functional abdominal pain (FAP), are common in adolescents and associated with impaired quality of life. In adults with IBS, internet-delivered CBT leads to reduced symptoms and increased quality of life, but studies in children are lacking. This pilot-study aim to evaluate the treatment effects and feasibility of an internet-delivered CBT-program for adolescents with FGID.
Method: Pilot study with a pre-post-design and no control group. The internet-delivered CBT-program l...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age between 13 and 17 years old.
- • a diagnosis of a functional gastrointestinal disorder by treating physician, e.g. IBS, FD or FAP.
- • adolescent and one parent should have easy access to the Internet, some computer experience and good Swedish language skills.
- Exclusion Criteria:
- • concurrent serious medical conditions or gastrointestinal symptoms likely caused by an organic disorder.
- • psychiatric diagnosis more urgent to treat than the abdominal pain.
- • on-going psychological treatment.
- • absence from school more than 20%.
- • on-going maltreatment, violence or severe parental psychiatric illness in the family.
- • pronounced language and learning difficulties depending on whether the youth was expected to benefit from the treatment or not.
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Patients applied
Trial Officials
Brjánn Ljótsson, PhD
Principal Investigator
Departement of clinical neuropsychology, Karolinska Institutet
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials